American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
- PMID: 26644543
- DOI: 10.1200/JCO.2015.64.3809
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Abstract
The purpose of the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline is to provide recommendations to assist primary care and other clinicians in the care of female adult survivors of breast cancer. A systematic review of the literature was conducted using PubMed through April 2015. A multidisciplinary expert workgroup with expertise in primary care, gynecology, surgical oncology, medical oncology, radiation oncology, and nursing was formed and tasked with drafting the Breast Cancer Survivorship Care Guideline. A total of 1,073 articles met inclusion criteria; and, after full text review, 237 were included as the evidence base. Patients should undergo regular surveillance for breast cancer recurrence, including evaluation with a cancer-related history and physical examination, and should be screened for new primary breast cancer. Data do not support performing routine laboratory tests or imaging tests in asymptomatic patients to evaluate for breast cancer recurrence. Primary care clinicians should counsel patients about the importance of maintaining a healthy lifestyle, monitor for post-treatment symptoms that can adversely affect quality of life, and monitor for adherence to endocrine therapy. Recommendations provided in this guideline are based on current evidence in the literature and expert consensus opinion. Most of the evidence is not sufficient to warrant a strong evidence-based recommendation. Recommendations on surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of physical and psychosocial long-term and late effects of breast cancer and its treatment, health promotion, and care coordination/practice implications are made.This guideline was developed through a collaboration between the American Cancer Society and the American Society of Clinical Oncology and has been published jointly by invitation and consent in both CA: A Cancer Journal for Clinicians and Journal of Clinical Oncology. All rights reserved. No part of this document may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission by the American Cancer Society or the American Society of Clinical Oncology.
© 2015 by American Cancer Society and American Society of Clinical Oncology.
Similar articles
-
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.CA Cancer J Clin. 2016 Jan-Feb;66(1):43-73. doi: 10.3322/caac.21319. Epub 2015 Dec 7. CA Cancer J Clin. 2016. PMID: 26641959
-
Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer.Cochrane Database Syst Rev. 2017 Jan 3;1(1):CD010802. doi: 10.1002/14651858.CD010802.pub2. Cochrane Database Syst Rev. 2017. PMID: 28045199 Free PMC article.
-
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.Clin Gastroenterol Hepatol. 2025 Jul;23(8):1291-1302. doi: 10.1016/j.cgh.2025.02.015. Epub 2025 May 19. Clin Gastroenterol Hepatol. 2025. PMID: 40387691 Review.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Cited by
-
Endocrine Therapy-related Endocrinopathies-Biology, Prevalence and Implications for the Management of Breast Cancer.Oncol Hematol Rev. 2020 Spring;16(1):17-22. doi: 10.17925/ohr.2020.16.1.17. Epub 2020 Feb 16. Oncol Hematol Rev. 2020. PMID: 33841882 Free PMC article.
-
Oncologists' perceived barriers to an expanded role for primary care in breast cancer survivorship care.Cancer Med. 2016 Sep;5(9):2198-204. doi: 10.1002/cam4.793. Epub 2016 Jun 30. Cancer Med. 2016. PMID: 27356781 Free PMC article.
-
Atti del 52° Congresso Nazionale: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI).J Prev Med Hyg. 2019 Oct 15;60(3 Suppl 1):E1-E384. doi: 10.15167/2421-4248/jpmh2019.60.3s1. eCollection 2019 Oct. J Prev Med Hyg. 2019. PMID: 31777763 Free PMC article. No abstract available.
-
Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors.Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):561-571. doi: 10.1158/1055-9965.EPI-22-0677. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36697364 Free PMC article.
-
Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit.CA Cancer J Clin. 2019 May;69(3):234-247. doi: 10.3322/caac.21558. Epub 2019 Mar 8. CA Cancer J Clin. 2019. PMID: 30849190 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous